The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

Previous work has shown an association between the K variant of the butyrylcholinesterase (BCHE) gene and Alzheimer's disease (AD) in patients carrying the epsilon4 allele of ApoE. We attempted to replicate this finding in 181 UK white AD cases and 71 controls. No difference was found in BCHE-K...

Description complète

Détails bibliographiques
Auteurs principaux:	Kehoe, P, Williams, H, Holmans, P, Wilcock, G, Cairns, N, Neal, J, Owen, M
Format:	Journal article
Langue:	English
Publié:	1998

Documents similaires

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.
par: Kehoe, P, et autres
Publié: (1999)

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
par: Kehoe, P, et autres
Publié: (1996)

Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
par: Roger M. Lane, et autres
Publié: (2024-04-01)

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.
par: Kehoe, P, et autres
Publié: (1996)

Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.
par: Lehmann, D, et autres
Publié: (2000)

Presenilin-1 polymorphism and Alzheimer's disease [6]
par: Kehoe, P, et autres
Publié: (1996)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
par: Holmes, C, et autres
Publié: (2005)

Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.
par: Kehoe, P, et autres
Publié: (2004)

ApoE epsilon 2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes
par: Horton, V, et autres
Publié: (2000)

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
par: Blomqvist, M, et autres
Publié: (2005)

Butyrylcholinesterase K variant is associated with type 2 diabetes in UK Caucasians
par: Hashim, Y, et autres
Publié: (2000)

Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients
par: Pongthanaracht N, et autres
Publié: (2017-05-01)

Flavonoids as Inhibitors of Human Butyrylcholinesterase Variants
par: Maja Katalinić, et autres
Publié: (2014-01-01)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
par: Kehoe, P, et autres
Publié: (2007)

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
par: Tasker, A, et autres
Publié: (2008)

Common variants of ACE contribute to variable age at onset of Alzheimer's disease
par: Katzov, H, et autres
Publié: (2004)

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
par: Katzov, H, et autres
Publié: (2004)

The renin angiotensin system in Alzheimer's disease - Do updates high-light a clinical and biological dichotomy?
par: Kehoe, P, et autres
Publié: (2006)

Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
par: Vitor G.L. Dantas, et autres
Publié: (2011-01-01)

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
par: Sani Muhammad Uzairu, et autres
Publié: (2022-09-01)

Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects.
par: Hashim, Y, et autres
Publié: (2001)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
par: Culpan, D, et autres
Publié: (2003)

Benzene-1,3-diol derivatives as the inhibitors of butyrylcholinesterase: An emergent target of Alzheimer’s disease
par: Dongliang Yin, et autres
Publié: (2022-01-01)

Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent
par: Shuang Miao, et autres
Publié: (2022-12-01)

Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could <i>BCHE</i> Genotyping Be Helpful in Alzheimer’s Therapy?
par: Jacek Jasiecki, et autres
Publié: (2019-10-01)

TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease
par: Culpan, D, et autres
Publié: (2004)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
par: Chalmers, K, et autres
Publié: (2004)

Widely Spread Butyrylcholinesterase Can Hydrolyze Acetylcholine in the Normal and Alzheimer Brain
par: Marsel Mesulam, et autres
Publié: (2002-02-01)

Haplotypes extending across ACE are associated with Alzheimer's disease.
par: Kehoe, P, et autres
Publié: (2003)

Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease
par: Chuanyu Yu, et autres
Publié: (2024-12-01)

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
par: Ana Matošević, et autres
Publié: (2022-09-01)

Investigation of Association between Susceptibility to Leprosy and SNPs inside and near the BCHE Gene of Butyrylcholinesterase
par: Henrique J. P. Gomes, et autres
Publié: (2012-01-01)

The ACE gene and Alzheimer's disease susceptibility.
par: Narain, Y, et autres
Publié: (2000)

Biophenols of mints: Antioxidant, acetylcholinesterase, butyrylcholinesterase and histone deacetylase inhibition activities targeting Alzheimer’s disease treatment
par: Doaa M. Hanafy, et autres
Publié: (2017-06-01)

Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer’s Disease
par: Mohamed Elsawalhy, et autres
Publié: (2024-10-01)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka.
par: Leo Pezzementi, et autres
Publié: (2011-01-01)

Treating Alzheimer's disease.
par: Wilcock, G, et autres
Publié: (1995)

Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes.
par: Leo Pezzementi, et autres
Publié: (2011-02-01)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
par: Miners, J, et autres
Publié: (2006)

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
par: Culpan, D, et autres
Publié: (2007)